Amyris Stock Price, News & Analysis (NASDAQ:AMRS)

$3.60 0.31 (9.42 %)
(As of 12/11/2017 04:00 PM ET)
Previous Close$3.29
Today's Range$3.31 - $3.65
52-Week Range$1.86 - $12.45
Volume315,485 shs
Average Volume259,147 shs
Market Capitalization$147.39 million
P/E RatioN/A
Dividend YieldN/A
Beta0.16

About Amyris (NASDAQ:AMRS)

Amyris logoAmyris, Inc. is an integrated industrial biotechnology company. The Company is engaged in research and development and sales of fuels and farnesene-derived products. It is applying its industrial synthetic biology platform to engineer, manufacture and sell products into a range of consumer and industrial markets, including cosmetics, flavors and fragrances (F&F), solvents and cleaners, polymers, lubricants, healthcare products and fuels. The Company focuses on a renewable hydrocarbon molecule called farnesene (Biofene). The Company is expanding its range of products across various categories divided into consumer and industrial applications. For consumer applications, the Company is developing and selling personal care products (which include ingredients for cosmetics and F&F), healthcare products and formulated end user products, such as Biossance brand skincare products and Muck Daddy brand hand cleaner product.

Receive AMRS News and Ratings via Email

Sign-up to receive the latest news and ratings for AMRS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Industrial Biotechnology Chemicals
Sub-IndustryOil & Gas Refining & Marketing
SectorBasic Materials
SymbolNASDAQ:AMRS
CUSIP03236M10
Phone+1-510-4500761

Debt

Debt-to-Equity Ratio-0.78%
Current Ratio0.92%
Quick Ratio0.82%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$77.19 million
Price / Sales2.01
Cash FlowN/A
Price / CashN/A
Book Value($10.05) per share
Price / Book-0.36

Profitability

Trailing EPS($6.19)
Net Income$-97,330,000.00
Net Margins-115.01%
Return on EquityN/A
Return on Assets-111.56%

Miscellaneous

Employees440
Outstanding Shares43,030,000

Amyris (NASDAQ:AMRS) Frequently Asked Questions

What is Amyris' stock symbol?

Amyris trades on the NASDAQ under the ticker symbol "AMRS."

When did Amyris' stock split? How did Amyris' stock split work?

Shares of Amyris reverse split before market open on Tuesday, June 6th 2017. The 1-15 reverse split was announced on Tuesday, June 6th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Amyris stock prior to the reverse split would have 7 shares after the split.

How were Amyris' earnings last quarter?

Amyris, Inc. (NASDAQ:AMRS) issued its earnings results on Tuesday, November, 14th. The biotechnology company reported ($0.81) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.77) by $0.04. The biotechnology company had revenue of $24.20 million for the quarter, compared to analysts' expectations of $36.30 million. Amyris's quarterly revenue was down 8.8% on a year-over-year basis. During the same quarter last year, the firm posted ($0.07) earnings per share. View Amyris' Earnings History.

When will Amyris make its next earnings announcement?

Amyris is scheduled to release their next quarterly earnings announcement on Wednesday, February, 28th 2018. View Earnings Estimates for Amyris.

Where is Amyris' stock going? Where will Amyris' stock price be in 2017?

3 analysts have issued 1 year price targets for Amyris' stock. Their forecasts range from $4.00 to $60.00. On average, they expect Amyris' stock price to reach $26.33 in the next year. View Analyst Ratings for Amyris.

Who are some of Amyris' key competitors?

Who are Amyris' key executives?

Amyris' management team includes the folowing people:

  • John G. Melo, President, Chief Executive Officer, Director (Age 49)
  • Kathleen Valiasek, Chief Financial Officer
  • Joel Cherry Ph.D., President - Research and Development (Age 54)
  • Eduardo Alvarez, Chief Operating Officer
  • Karen D. Rohde, Chief Human Resources Officer
  • Karen Weaver, Principal Accounting Officer, Vice President - Finance
  • Chris Jaenike, Interim General Counsel
  • Philip Eykerman, Director (Age 49)
  • Christoph Goppelsroeder, Director
  • Frank F. C. Kung Ph.D., Director

Who owns Amyris stock?

Amyris' stock is owned by many different of institutional and retail investors. Top institutional shareholders include TEMASEK HOLDINGS (PRIVATE) LTD (13.10%), Tanaka Capital Management Inc. (1.41%), KBC Group NV (0.16%) and Carl Domino Inc (0.15%). Company insiders that own Amyris stock include (Mauritius) Pte Ltd Maxwell, L John Doerr and Patrick Y Yang. View Institutional Ownership Trends for Amyris.

Who bought Amyris stock? Who is buying Amyris stock?

Amyris' stock was purchased by a variety of institutional investors in the last quarter, including Tanaka Capital Management Inc., Carl Domino Inc and KBC Group NV. Company insiders that have bought Amyris stock in the last two years include L John Doerr and Patrick Y Yang. View Insider Buying and Selling for Amyris.

How do I buy Amyris stock?

Shares of Amyris can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amyris' stock price today?

One share of Amyris stock can currently be purchased for approximately $3.60.

How big of a company is Amyris?

Amyris has a market capitalization of $147.39 million and generates $77.19 million in revenue each year. The biotechnology company earns $-97,330,000.00 in net income (profit) each year or ($6.19) on an earnings per share basis. Amyris employs 440 workers across the globe.

How can I contact Amyris?

Amyris' mailing address is 5885 Hollis St Ste 100, EMERYVILLE, CA 94608-2405, United States. The biotechnology company can be reached via phone at +1-510-4500761 or via email at [email protected]


MarketBeat Community Rating for Amyris (AMRS)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  181 (Vote Underperform)
Total Votes:  300
MarketBeat's community ratings are surveys of what our community members think about Amyris and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amyris (NASDAQ:AMRS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.752.752.752.75
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $30.25$30.25$30.25$36.75
Price Target Upside: 715.36% upside764.29% upside1,268.78% upside920.83% upside

Amyris (NASDAQ:AMRS) Consensus Price Target History

Price Target History for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ:AMRS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/29/2017HC WainwrightSet Price TargetBuy$15.00HighView Rating Details
11/29/2017CowenReiterated RatingHold$4.00HighView Rating Details
1/11/2017Rodman & RenshawReiterated RatingBuy$60.00N/AView Rating Details
9/28/2016Singular ResearchReiterated RatingBuy$42.00N/AView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Amyris (NASDAQ:AMRS) Earnings History and Estimates Chart

Earnings by Quarter for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ AMRS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2018$0.12N/AView Earnings Details
11/14/2017Q3 2017($0.77)($0.81)$36.30 million$24.20 millionViewN/AView Earnings Details
8/10/2017Q2 2017($1.06)($1.41)$23.68 million$25.68 millionViewN/AView Earnings Details
5/15/2017Q1 2017($1.35)($1.95)$32.30 million$13.00 millionViewN/AView Earnings Details
3/2/2017Q4 2016($0.75)($1.50)$38.72 million$32.20 millionViewListenView Earnings Details
11/2/2016Q316($0.90)($1.05)$33.61 million$26.50 millionViewN/AView Earnings Details
8/4/2016Q2($1.80)($0.90)$15.23 million$9.60 millionViewN/AView Earnings Details
5/10/2016Q1($1.95)($2.55)$10.39 million$8.80 millionViewListenView Earnings Details
3/9/2016Q4($1.50)($2.40)$32.44 million$9.80 millionViewListenView Earnings Details
11/5/2015Q315($2.55)($3.45)$8.84 million$8.60 millionViewN/AView Earnings Details
8/6/2015Q215($4.65)($7.95)$15.66 million$7.80 millionViewN/AView Earnings Details
5/5/2015Q115($1.50)($6.15)$21.40 million$7.90 millionViewN/AView Earnings Details
2/24/2015Q414($3.00)($12.60)$20.12 million$11.60 millionViewN/AView Earnings Details
11/4/2014Q314($2.10)($4.20)$20.51 million$16.34 millionViewN/AView Earnings Details
8/7/2014Q214($5.55)($5.25)$12.36 million$9.30 millionViewN/AView Earnings Details
5/8/2014Q114($4.80)($5.40)$13.50 million$17.90 millionViewN/AView Earnings Details
2/25/2014Q413($3.60)($3.90)$18.66 millionViewN/AView Earnings Details
10/31/2013Q313($4.50)($4.80)$13.59 million$7.00 millionViewN/AView Earnings Details
8/8/2013Q2 2013($4.80)($5.10)$11.47 million$10.80 millionViewN/AView Earnings Details
4/30/2013Q1 2013($5.85)($5.85)$9.80 million$7.87 millionViewN/AView Earnings Details
2/19/2013Q4 2012($7.65)($7.35)$10.68 million$5.90 millionViewN/AView Earnings Details
11/6/2012Q312($9.45)($3.30)$10.49 million$19.10 millionViewN/AView Earnings Details
7/31/2012($10.35)($9.90)ViewN/AView Earnings Details
5/8/2012($11.40)($28.20)ViewN/AView Earnings Details
11/1/2011($10.65)($14.55)ViewN/AView Earnings Details
8/2/2011($9.45)($14.25)ViewN/AView Earnings Details
5/5/2011($7.50)($11.40)ViewN/AView Earnings Details
2/28/2011($7.35)($7.65)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Amyris (NASDAQ:AMRS) Earnings Estimates

Current Year EPS Consensus Estimate: $-3.32 EPS
Next Year EPS Consensus Estimate: $-1.07 EPS

Dividends

Dividend History for Amyris (NASDAQ:AMRS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Amyris (NASDAQ AMRS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 11.30%
Institutional Ownership Percentage: 22.84%
Insider Trades by Quarter for Amyris (NASDAQ:AMRS)
Institutional Ownership by Quarter for Amyris (NASDAQ:AMRS)

Amyris (NASDAQ AMRS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/19/2017Patrick Y YangDirectorBuy300,000$0.29$87,000.00View SEC Filing  
4/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell652,513$0.55$358,882.15View SEC Filing  
4/18/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,636,930$0.65$1,064,004.50View SEC Filing  
3/30/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell184,535$0.51$94,112.85View SEC Filing  
3/29/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell417,990$0.51$213,174.90View SEC Filing  
3/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell129,059$0.48$61,948.32View SEC Filing  
3/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell165,428$0.48$79,405.44View SEC Filing  
3/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell223,073$0.48$107,075.04View SEC Filing  
3/20/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell88,382$0.49$43,307.18View SEC Filing  
3/17/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell339,908$0.49$166,554.92View SEC Filing  
3/15/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell270,374$0.46$124,372.04View SEC Filing  
3/13/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell346,429$0.50$173,214.50View SEC Filing  
3/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell520,925$0.46$239,625.50View SEC Filing  
3/7/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell852,224$0.45$383,500.80View SEC Filing  
3/3/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell868,589$0.49$425,608.61View SEC Filing  
3/1/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell377,823$0.51$192,689.73View SEC Filing  
2/27/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,706$0.52$149,607.12View SEC Filing  
2/23/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell529,747$0.53$280,765.91View SEC Filing  
2/21/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell287,528$0.56$161,015.68View SEC Filing  
2/16/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell390,918$0.54$211,095.72View SEC Filing  
2/10/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell429,198$0.51$218,890.98View SEC Filing  
2/8/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell288,765$0.50$144,382.50View SEC Filing  
1/12/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell29,502$0.81$23,896.62View SEC Filing  
1/11/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell451,806$0.81$365,962.86View SEC Filing  
1/9/2017(Mauritius) Pte Ltd MaxwellMajor ShareholderSell1,072,847$0.81$869,006.07View SEC Filing  
12/14/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell87,291$0.80$69,832.80View SEC Filing  
12/12/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell54,286$0.80$43,428.80View SEC Filing  
12/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell285,623$0.81$231,354.63View SEC Filing  
12/6/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell578,550$0.81$468,625.50View SEC Filing  
12/2/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell556,296$0.84$467,288.64View SEC Filing  
11/22/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell77,383$0.80$61,906.40View SEC Filing  
11/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell509,779$0.81$412,920.99View SEC Filing  
11/15/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell648,342$0.81$525,157.02View SEC Filing  
11/11/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell427,904$0.81$346,602.24View SEC Filing  
11/8/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell333,811$0.82$273,725.02View SEC Filing  
11/4/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,611,233$0.89$2,323,997.37View SEC Filing  
10/17/2016(Mauritius) Pte Ltd MaxwellMajor ShareholderSell2,300,000$0.83$1,909,000.00View SEC Filing  
6/14/2016L John DoerrDirectorBuy200,577$1.04$208,600.08View SEC Filing  
10/14/2015Energies Nouvelles Activ TotalDirectorSell80,052$2.36$188,922.72View SEC Filing  
6/5/2015John MeloCEOSell61,276$2.00$122,552.00View SEC Filing  
5/12/2015John MeloCEOSell65,575$2.08$136,396.00View SEC Filing  
5/15/2014L John DoerrDirectorBuy172,186$3.02$520,001.72View SEC Filing  
5/24/2013John MeloCEOSell24,402$2.85$69,545.70View SEC Filing  
3/27/2013Thani Sheikh Abdullah Bin K AlDirectorBuy1,533,742$3.26$4,999,998.92View SEC Filing  
12/24/2012Thani Sheikh Abdullah Bin K AlDirectorBuy3,355,704$2.98$9,999,997.92View SEC Filing  
8/31/2012John MeloCEOSell668,730$3.70$2,474,301.00View SEC Filing  
8/31/2012L John DoerrDirectorBuy270,270$3.70$999,999.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Amyris (NASDAQ AMRS) News Headlines

Source:
DateHeadline
Mid-Day Market Update: Crude Oil Up Over 1%; Syros Pharmaceuticals Shares Plunge - NasdaqMid-Day Market Update: Crude Oil Up Over 1%; Syros Pharmaceuticals Shares Plunge - Nasdaq
www.nasdaq.com - December 11 at 3:19 PM
ETFs with exposure to Amyris, Inc. : December 11, 2017ETFs with exposure to Amyris, Inc. : December 11, 2017
finance.yahoo.com - December 11 at 3:19 PM
Amyris (AMRS) Downgraded by ValuEngine to "Strong Sell"Amyris (AMRS) Downgraded by ValuEngine to "Strong Sell"
www.americanbankingnews.com - December 3 at 11:40 PM
ETFs with exposure to Amyris, Inc. : November 30, 2017ETFs with exposure to Amyris, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 3:19 PM
Cowen Reiterates "Hold" Rating for Amyris (AMRS)Cowen Reiterates "Hold" Rating for Amyris (AMRS)
www.americanbankingnews.com - November 29 at 7:30 PM
Amyris, Inc. :AMRS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017Amyris, Inc. :AMRS-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 3:19 PM
Amyris (AMRS) Given a $15.00 Price Target by HC Wainwright AnalystsAmyris (AMRS) Given a $15.00 Price Target by HC Wainwright Analysts
www.americanbankingnews.com - November 29 at 12:22 PM
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - GlobeNewswire (press release)Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - GlobeNewswire (press release)
globenewswire.com - November 23 at 2:28 AM
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - NasdaqAmyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for ... - Nasdaq
www.nasdaq.com - November 21 at 9:26 PM
Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017Amyris Schedules Teleconference to Provide Additional Details on Expanded Strategic Alliance with Royal DSM for Tuesday, November 28, 2017
finance.yahoo.com - November 21 at 4:24 PM
HC Wainwright Reaffirms "Buy" Rating for Amyris, Inc. (AMRS)HC Wainwright Reaffirms "Buy" Rating for Amyris, Inc. (AMRS)
www.americanbankingnews.com - November 19 at 5:38 PM
DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris - GlobeNewswire (press release)DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris - GlobeNewswire (press release)
globenewswire.com - November 18 at 8:52 PM
DSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from AmyrisDSM Expands Strategic Alliance with Amyris and Acquires Brazilian Production Facility from Amyris
finance.yahoo.com - November 17 at 10:44 AM
Edited Transcript of AMRS earnings conference call or presentation 14-Nov-17 9:30pm GMTEdited Transcript of AMRS earnings conference call or presentation 14-Nov-17 9:30pm GMT
finance.yahoo.com - November 16 at 11:13 AM
Amyris reports 3Q lossAmyris reports 3Q loss
finance.yahoo.com - November 16 at 11:13 AM
Amyris, Inc. (AMRS) Releases Quarterly  Earnings Results, Misses Expectations By $0.04 EPSAmyris, Inc. (AMRS) Releases Quarterly Earnings Results, Misses Expectations By $0.04 EPS
www.americanbankingnews.com - November 15 at 10:34 AM
Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017 - GlobeNewswire (press release)Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017 - GlobeNewswire (press release)
globenewswire.com - November 14 at 4:21 PM
Amyris, Inc. to Host Earnings CallAmyris, Inc. to Host Earnings Call
finance.yahoo.com - November 14 at 4:21 PM
Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017Amyris Reports Another Strong Quarter of Product Sales Growth and Expects Strong Finish for 2017
finance.yahoo.com - November 14 at 4:21 PM
Carl Domino Inc Buys DowDuPont Inc, Bank of America Corporation, CenturyLink Inc, Sells Paychex ...Carl Domino Inc Buys DowDuPont Inc, Bank of America Corporation, CenturyLink Inc, Sells Paychex ...
www.nasdaq.com - November 8 at 8:34 PM
Should You Worry About Amyris Inc’s (AMRS) CEO Pay?Should You Worry About Amyris Inc’s (AMRS) CEO Pay?
finance.yahoo.com - November 8 at 3:27 PM
Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017 - GlobeNewswire (press release)Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017 - GlobeNewswire (press release)
globenewswire.com - November 8 at 6:15 AM
Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017Amyris Reschedules Third Quarter 2017 Financial Results Teleconference for Tuesday, November 14, 2017
finance.yahoo.com - November 7 at 10:38 PM
Amyris, Inc. (AMRS) Set to Announce Quarterly Earnings on WednesdayAmyris, Inc. (AMRS) Set to Announce Quarterly Earnings on Wednesday
www.americanbankingnews.com - November 1 at 8:08 PM
Interested In The Energy Industry? Take A Look At Amyris Inc (AMRS)Interested In The Energy Industry? Take A Look At Amyris Inc (AMRS)
finance.yahoo.com - October 31 at 5:05 PM
ETFs with exposure to Amyris, Inc. : October 27, 2017ETFs with exposure to Amyris, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 6:00 PM
H&R Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil TechnologyH&R Makes Equity Investment in Novvi and its High-Performance Renewable Base Oil Technology
finance.yahoo.com - October 26 at 10:46 AM
Amyris to Announce Third Quarter 2017 Financial Results on Wednesday, November 8, 2017Amyris to Announce Third Quarter 2017 Financial Results on Wednesday, November 8, 2017
finance.yahoo.com - October 25 at 4:55 PM
Amyris, Inc. (AMRS) Set to Announce Quarterly Earnings on TuesdayAmyris, Inc. (AMRS) Set to Announce Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 24 at 9:58 AM
Amyris, Inc. (AMRS) Downgraded to "Hold" at Zacks Investment ResearchAmyris, Inc. (AMRS) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - October 23 at 8:10 PM
ETFs with exposure to Amyris, Inc. : October 12, 2017ETFs with exposure to Amyris, Inc. : October 12, 2017
finance.yahoo.com - October 12 at 4:38 PM
Amyris (AMRS) Names Eduardo Alvarez COOAmyris (AMRS) Names Eduardo Alvarez COO
www.streetinsider.com - October 9 at 9:57 PM
Amyris (AMRS) Names Eduardo Alvarez COO - StreetInsider.comAmyris (AMRS) Names Eduardo Alvarez COO - StreetInsider.com
www.streetinsider.com - October 9 at 4:52 PM
Amyris Appoints Chief Operating Officer to Support Continued Strong GrowthAmyris Appoints Chief Operating Officer to Support Continued Strong Growth
feeds.benzinga.com - October 9 at 8:52 AM
Amyris, Inc. (AMRS) Lifted to "Buy" at Zacks Investment ResearchAmyris, Inc. (AMRS) Lifted to "Buy" at Zacks Investment Research
www.americanbankingnews.com - October 4 at 8:32 PM
ETFs with exposure to Amyris, Inc. : September 28, 2017ETFs with exposure to Amyris, Inc. : September 28, 2017
finance.yahoo.com - October 2 at 3:39 PM
How Does Amyris Inc (AMRS) Affect Your Portfolio Returns?How Does Amyris Inc (AMRS) Affect Your Portfolio Returns?
finance.yahoo.com - October 2 at 3:39 PM
Amyris (AMRS) "Buy" Rating Reaffirmed at HC WainwrightAmyris' (AMRS) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - September 26 at 1:16 PM
ETFs with exposure to Amyris, Inc. : September 13, 2017ETFs with exposure to Amyris, Inc. : September 13, 2017
finance.yahoo.com - September 13 at 10:05 PM
Amyris (AMRS) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - SlideshowAmyris (AMRS) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow
seekingalpha.com - September 12 at 4:05 PM
Amyris, Inc. (AMRS) Given Consensus Rating of "Hold" by AnalystsAmyris, Inc. (AMRS) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - September 11 at 2:22 AM
Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017Amyris to Present at Rodman & Renshaw 19th Annual Global Investment Conference on September 11, 2017
finance.yahoo.com - September 6 at 3:45 PM
ETFs with exposure to Amyris, Inc. : August 31, 2017ETFs with exposure to Amyris, Inc. : August 31, 2017
finance.yahoo.com - September 1 at 1:14 AM
Amyris, Inc. (AMRS) Short Interest Up 43.2% in AugustAmyris, Inc. (AMRS) Short Interest Up 43.2% in August
www.americanbankingnews.com - August 28 at 1:20 AM
Amyris, Inc. :AMRS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017Amyris, Inc. :AMRS-US: Earnings Analysis: Q2, 2017 By the Numbers : August 25, 2017
finance.yahoo.com - August 25 at 5:26 PM
Amyris, Inc. (AMRS) Given a $4.00 Price Target by Cowen and Company AnalystsAmyris, Inc. (AMRS) Given a $4.00 Price Target by Cowen and Company Analysts
www.americanbankingnews.com - August 20 at 8:16 PM
Amyris, Inc. (AMRS) Receives Average Recommendation of "Hold" from AnalystsAmyris, Inc. (AMRS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - August 17 at 2:32 AM
HC Wainwright Analysts Give Amyris, Inc. (NASDAQ:AMRS) a $15.00 Price TargetHC Wainwright Analysts Give Amyris, Inc. (NASDAQ:AMRS) a $15.00 Price Target
www.americanbankingnews.com - August 13 at 3:32 PM
Edited Transcript of AMRS earnings conference call or presentation 10-Aug-17 8:30pm GMTEdited Transcript of AMRS earnings conference call or presentation 10-Aug-17 8:30pm GMT
finance.yahoo.com - August 12 at 2:26 AM
Amyris, Inc. (AMRS) Posts  Earnings Results, Misses Estimates By $0.30 EPSAmyris, Inc. (AMRS) Posts Earnings Results, Misses Estimates By $0.30 EPS
www.americanbankingnews.com - August 10 at 9:35 PM

SEC Filings

Amyris (NASDAQ:AMRS) SEC Filings

DateFilerForm TypeView
12/11/2017
4:15 PM
Amyris (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/05/2017
6:30 PM
Amyris (Issuer)
WEAVER KAREN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/05/2017
4:05 PM
Amyris (Filer)
Form 424B3
View Filing
12/04/2017
4:15 PM
Amyris (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/03/2017
11:15 PM
Amyris (Filer)
Form EFFECT
View Filing
11/29/2017
3:05 PM
Amyris (Subject)
DSM International B.V. (Filed by)
Form SC 13D/A
View Filing

Social Media

Financials

Amyris (NASDAQ:AMRS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amyris (NASDAQ AMRS) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.